Drugs / Erigeron breviscapus
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2/3 | NCT07591883 | Jun 2026 → Jul 2029 expected | ischemic stroke | Guangdong Provincial Hospital of Traditional Chinese Medicine | Not yet recruiting | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Erigeron breviscapus | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07591883 ↗ |